Reducing Immunosuppression in Patients with De Novo Lung Carcinoma after Liver Transplantation Could Significantly Prolong Survival

Reducing Immunosuppression in Patients with De Novo Lung Carcinoma after Liver Transplantation Could Significantly Prolong Survival

(1) Background: Liver transplantation (LT) is an established treatment for selected patients with end-stage liver disease resulting in a subsequent need for long-term immunosuppressive therapy. With cumulative exposure to immunosuppression (IS), the risk for the development of de novo lung carcinoma...

Full description

Bibliographic Details
Main Authors: Sina Pesthy, Elisa Wegener, Ramin Raul Ossami Saidy, Lea Timmermann, Deniz Uluk, Mustafa Aydin, Tomasz Dziodzio, Wenzel Schoening, Georg Lurje, Robert Öllinger, Nikolaj Frost, Uli Fehrenbach, Jens-Carsten Rückert, Jens Neudecker, Johann Pratschke, Dennis Eurich
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
liver transplantation
de novo lung cancer
lung carcinoma
immunosuppression
surgical tumor resection
Online Access:https://www.mdpi.com/2072-6694/14/11/2748

Internet

https://www.mdpi.com/2072-6694/14/11/2748

Similar Items